<SEC-DOCUMENT>0001104659-22-072110.txt : 20220617
<SEC-HEADER>0001104659-22-072110.hdr.sgml : 20220617
<ACCEPTANCE-DATETIME>20220617063024
ACCESSION NUMBER:		0001104659-22-072110
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20220616
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220617
DATE AS OF CHANGE:		20220617

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EYENOVIA, INC.
		CENTRAL INDEX KEY:			0001682639
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				471178401
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38365
		FILM NUMBER:		221022358

	BUSINESS ADDRESS:	
		STREET 1:		295 MADISON AVENUE,
		STREET 2:		SUITE 2400
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		813-766-9539

	MAIL ADDRESS:	
		STREET 1:		295 MADISON AVENUE,
		STREET 2:		SUITE 2400
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2218686d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:eyen="http://eyenoviabio.com/20220616">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_eyen_eyenoviabio.com_20220616 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20220616_20220616_z5yJkDdL8LZ4 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0001682639 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-06-16to2022-06-16" name="dei:EntityCentralIndexKey">0001682639</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-06-16to2022-06-16" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="eyen-20220616.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-06-16to2022-06-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001682639</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-16</xbrli:startDate>
        <xbrli:endDate>2022-06-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_909_edei--DocumentType_c20220616__20220616_zqayks0hvMz4"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="border-bottom: Black 1pt solid; font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_90D_edei--DocumentPeriodEndDate_c20220616__20220616_z0cZzm9tw6Mb"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 16, 2022</ix:nonNumeric></span></b></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90E_edei--EntityRegistrantName_c20220616__20220616_zVHg7NwSwIyj" style="font-size: 24pt"><b><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" name="dei:EntityRegistrantName">EYENOVIA,
INC.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact Name of Registrant as Specified in its Charter)</b></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 32%; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20220616__20220616_zsGFQGxzFw9a"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td rowspan="2" style="width: 2%">&#160;</td>
    <td style="width: 32%; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90B_edei--EntityFileNumber_c20220616__20220616_znCCprdzQPZ7"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" name="dei:EntityFileNumber">001-38365</ix:nonNumeric></span></b></span></td>
    <td rowspan="2" style="width: 2%">&#160;</td>
    <td style="width: 32%; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20220616__20220616_z45YfePMEIb3"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" name="dei:EntityTaxIdentificationNumber">47-1178401</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(State or other jurisdiction<br />
    of incorporation)</b></p></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Commission <br />
    File Number)</b></p></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(IRS Employer</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Identification No.)</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90D_edei--EntityAddressAddressLine1_c20220616__20220616_zq2vSNHTIm6i"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" name="dei:EntityAddressAddressLine1">295 Madison Avenue</ix:nonNumeric></span>,</b> <b><span id="xdx_900_edei--EntityAddressAddressLine2_c20220616__20220616_zzR3ajYIo95f"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" name="dei:EntityAddressAddressLine2">Suite 2400</ix:nonNumeric></span>,</b> <b><span id="xdx_904_edei--EntityAddressCityOrTown_c20220616__20220616_zCcNXGYc7YWb"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span></b><b>, </b><b><span id="xdx_906_edei--EntityAddressStateOrProvince_c20220616__20220616_zcecYZcthTd9"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></span></b> <b><span id="xdx_904_edei--EntityAddressPostalZipCode_c20220616__20220616_z0EkY4WEAlXc"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" name="dei:EntityAddressPostalZipCode">10017</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Address of Principal Executive Offices, and
Zip Code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_905_edei--CityAreaCode_c20220616__20220616_zmyvOkvQTe1"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" name="dei:CityAreaCode">917</ix:nonNumeric></span>)</b> <b><span id="xdx_90B_edei--LocalPhoneNumber_c20220616__20220616_zJyRyXyGEzm9"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" name="dei:LocalPhoneNumber">289-1117</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registrant&#8217;s Telephone Number, Including
Area Code</b>&#160;</p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_907_edei--WrittenCommunications_c20220616__20220616_zgVEg4Kle79b"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)</td>
</tr></table>

<p style="font: 2pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_900_edei--SolicitingMaterial_c20220616__20220616_z5cJNbIhjrwk"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)</td>
</tr></table>

<p style="font: 2pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_904_edei--PreCommencementTenderOffer_c20220616__20220616_zIYZmHCMvRD2"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>

<p style="font: 2pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20220616__20220616_z0kDDkApGlH4"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 32%; padding-bottom: 1pt; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b>(Title of each class)</b></span></td>
    <td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; padding-bottom: 1pt; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b>(Trading <br />
Symbol)</b></span></td>
    <td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Name of each exchange<br />
on which registered)</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 10pt; padding-left: 10.1pt; font-size: 10pt; text-align: center"><span id="xdx_906_edei--Security12bTitle_c20220616__20220616_zD0yCaK0LcUc" style="font-size: 10pt"><b><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" name="dei:Security12bTitle">Common
    stock, $0.0001 par value</ix:nonNumeric></b></span></td>
    <td><b>&#160;</b></td>
    <td style="padding-bottom: 10pt; font-size: 10pt; text-align: center"><span id="xdx_905_edei--TradingSymbol_c20220616__20220616_zr7oBDTNrOaf" style="font-size: 10pt"><b><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" name="dei:TradingSymbol">EYEN</ix:nonNumeric></b></span></td>
    <td><b>&#160;</b></td>
    <td style="font-size: 10pt; text-align: center"><b><span id="xdx_905_edei--SecurityExchangeName_c20220616__20220616_zU6vIddCTlDb" style="font-size: 10pt"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market</ix:nonNumeric></span><br />
    (Nasdaq Capital Market)</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company&#160;&#160;<span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20220616__20220616_z7qFNhJsuCE8"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#120;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90B_edei--EntityExTransitionPeriod_c20220616__20220616_zK8Rv6wmI8t6"><ix:nonNumeric contextRef="From2022-06-16to2022-06-16" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 5.02.</b></td><td><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(e) &#160;&#160;&#160;&#160;&#160;&#160;&#160;</b>The
2022 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) of Eyenovia, Inc. (&#8220;Eyenovia&#8221;) was held in a virtual
format on June 16, 2022 at 10:00 AM EDT. At the Annual Meeting, the stockholders approved an amendment to the Eyenovia, Inc. 2018 Omnibus
Stock Incentive Plan (the &#8220;Amended and Restated Plan&#8221;), reserving an additional 1,500,000 shares of common stock for further
issuance under such plan. Eyenovia&#8217;s Board of Directors approved the Amended and Restated Plan on February 28, 2022, subject to
stockholder approval.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of the principal
features of the Amended and Restated Plan can be found in the definitive proxy statement for the Annual Meeting, filed with the Securities
and Exchange Commission on May 2, 2022 (the &#8220;2022 Proxy Statement&#8221;), under the heading &#8220;Proposal Two &#8211; Amendment
to the Eyenovia, Inc. 2018 Omnibus Stock Incentive Plan.&#8221; The summary of the Amended and Restated Plan contained in the 2022 Proxy
Statement is qualified in its entirety by the full text of the Amended and Restated Plan filed as Exhibit 10.1 to this Current Report
on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0"></td><td style="width: 1in; text-align: left"><b>Item 5.07.</b></td><td style="text-align: justify"><b>Submission of Matters to a Vote of Security Holders.</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The actions set forth below
were taken at the Annual Meeting. Of Eyenovia&#8217;s 31,698,424 shares of common stock issued and eligible to vote as of the record date
of April 18, 2022, a quorum of 20,525,083 shares, or approximately 64.75% of the eligible shares, was present virtually or represented
by proxy. Each of the matters set forth below is described in detail in the 2022 Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1. Election of the following nominees of Eyenovia,
to serve a one-year term expiring in 2023 or until their successors have been elected and qualified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif">Nominee</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares <br /> Voted For</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares Voted<br /> to Withhold Authority</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Broker <br /> Non-Votes</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: left">Stephen Benjamin</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; width: 10%; text-align: right">11,008,713</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; width: 10%; text-align: right">1,165,053</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; width: 10%; text-align: right">8,351,317</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Julia A. Haller, M.D.</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">11,911,116</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">262,650</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">8,351,317</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tsontcho Ianchulev, M.D., M.P.H</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">12,023,241</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">150,525</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">8,351,317</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Rachel Jacobson</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">11,082,708</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">1,091,058</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">8,351,317</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kenneth B. Lee, Jr.</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">12,016,788</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">156,978</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">8,351,317</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Charles E. Mather IV</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">11,910,051</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">263,715</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: right">8,351,317</td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 8pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">2.
Approval of the Amended and Restated Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares <br />
Voted For</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares Voted<br />
Against</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares<br />
Abstaining</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker <br />
Non-Votes</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 40%; padding-left: 5.65pt; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 12%; text-align: center"><span style="font-family: Symbol; font-size: 10pt">10,516,638</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 12%; text-align: center"><span style="font-family: Symbol; font-size: 10pt">1,377,685</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 12%; text-align: center"><span style="font-family: Symbol; font-size: 10pt">279,443</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,351,317</span></td>
    <td style="width: 1%; text-align: center">&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3. Ratification of the appointment of Marcum LLP as Eyenovia&#8217;s
independent registered public accounting firm for the fiscal year ending December 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares <br />
Voted For</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares Voted<br />
Against</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares<br />
Abstaining</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="background-color: white; text-align: center">&#160;</td>
    <td style="background-color: white; text-align: center">&#160;</td>
    <td style="background-color: white; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker <br />
Non-votes</b>&#160;</span></td>
    <td style="background-color: white; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 40%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,469,369</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,973</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,741</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="width: 1%; text-align: center">&#160;</td></tr>
  <tr>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 72.5pt"><b>Item 9.01.</b></td><td><b>Financial Statements and Exhibits.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 85%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><a href="tm2218686d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></a></td>
    <td><a href="tm2218686d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eyenovia,
Inc. Amended and Restated 2018 Omnibus Stock Incentive Plan</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>104</td>
    <td>Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%; padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EYENOVIA,&#160;INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: June 17, 2022</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ John Gandolfo</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John Gandolfo</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OUwlI3xMKiILkYhelxxjSXdkdrX8pP6yTYmGgWHmzrlXiJnY0VbVyHBdFxmcsWlraREKrJBR39B9pPtDAm4WeFfGstR2XH9gSo5Bx8T+Srr7+Nkrg2UCwXIexvMohGCRhBHkR+F99ZR0pUrUVskapC4hZ2pZoZU8TA5n+SJNzTAmXZCNIp1A6AeT/IYocH4n6uWT+GEgy1LhzcbyxI6pa78xnbHUwKbGxmWZCf239wHepUka -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2218686d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: right; text-indent: 5.5in"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center; text-indent: 5.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>EYENOVIA, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>AMENDED AND RESTATED<BR>
2018 OMNIBUS STOCK INCENTIVE PLAN, AS AMENDED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>2018 Omnibus Stock Incentive Plan
Approved by<BR>
the Board and Stockholders on March 6, 2018 and June 11, 2018, respectively</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>Amendment to 2018 Omnibus Stock Incentive
Plan Approved by<BR>
the Board and Stockholders on April 5, 2019 and June 11, 2019, respectively</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>Amendment and Restatement of 2018
Omnibus Stock Incentive Plan Approved by<BR>
the Board and Stockholders on April 7, 2020 and June 30, 2020, respectively</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>Amendment to Amended and Restated
2018 Omnibus Stock Incentive Plan Approved by<BR>
the Board and Stockholders on March 31, 2021 and June 16, 2021, respectively</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>Amendment to Amended and Restated
2018 Omnibus Stock Incentive Plan Approved by<BR>
the Board and Stockholders on February 28, 2022 and June 16, 2022, respectively</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Purposes of the Plan</U>. The purposes of this Plan are to attract and retain the best available personnel; to provide additional
incentives to Employees, Directors and Consultants to contribute to the successful performance of the Company and any Related Entity;
to promote the growth of the market value of the Company&rsquo;s Common Stock; to align the interests of Grantees with those of the Company&rsquo;s
stockholders; and to promote the success of the Company&rsquo;s business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Definitions</U>. The following definitions shall apply as used herein and in all individual Award Agreements except as a term
may be otherwise defined in an individual Award Agreement. In the event a term is separately defined in an individual Award Agreement,
such definition shall supersede the definition contained in this Section 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Administrator&rdquo; </I></B>means the Plan Administrator as described in Section 4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Applicable Laws&rdquo; </I></B>means the legal requirements relating to the Plan and the Awards under applicable provisions
of federal and state securities laws, the corporate laws of Delaware, and, to the extent other than Delaware, the corporate law of the
state of the Company&rsquo;s incorporation, the Code, the rules of any applicable stock exchange or national market system, and the rules
of any non-U.S. jurisdiction applicable to Awards granted to residents therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Assumed&rdquo; </I></B>means, with respect to an Award, that pursuant to a Corporate Transaction either (i) the Award
is expressly affirmed by the Company or (ii) the contractual obligations represented by the Award are expressly assumed (and not simply
by operation of law) by the successor entity or its Parent in connection with the Corporate Transaction with appropriate adjustments to
the number and type of securities of the successor entity or its Parent subject to the Award and the exercise or purchase price thereof
which at least preserves the compensation element of the Award existing at the time of the Corporate Transaction as determined in accordance
with the instruments evidencing the agreement to assume the Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Award&rdquo; </I></B>means the grant of an Option, SAR, Dividend Equivalent Right, Restricted Stock, Restricted Stock
Unit, or other right or benefit under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Award Agreement&rdquo; </I></B>means the written agreement evidencing the grant of an Award executed by the Company
and the Grantee, including any amendments thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Board&rdquo; </I></B>means the Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&ldquo;Cause&rdquo;
</I></B>means, with respect to the termination by the Company or a Related Entity of a Grantee&rsquo;s Continuous Service:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>that such termination is for &ldquo;Cause&rdquo; as such term (or word of like import) is expressly defined in a then-effective
written employment agreement, consulting agreement, service agreement or other similar agreement between the Grantee and the Company or
such Related Entity, provided, however, that with regard to any agreement that defines &ldquo;Cause&rdquo; on the occurrence of or in
connection with a Corporate Transaction, such definition of &ldquo;Cause&rdquo; shall not apply until a Corporate Transaction actually
occurs; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT>in the absence of such then-effective written agreement and definition, is based on, in the determination of the Administrator:
(A) the Grantee&rsquo;s performance of any act, or failure to perform any act, in bad faith and to the detriment of the Company or a Related
Entity; (B) the Grantee&rsquo;s dishonesty, intentional misconduct or material breach of any agreement with the Company or a Related Entity;
(C) the Grantee&rsquo;s material breach of any noncompetition, confidentiality or similar agreement with the Company or a Related Entity,
as determined under such agreement; (D) the Grantee&rsquo;s commission of a crime involving dishonesty, breach of trust, or physical or
emotional harm to any person; (E) if the Grantee is an Employee or Consultant, the Grantee&rsquo;s engaging in acts or omissions constituting
gross negligence, misconduct or a willful violation of a Company or a Related Entity policy which is or is reasonably expected to be materially
injurious to the Company and/or a Related Entity; or (F) if the Grantee is an Employee, the Grantee&rsquo;s failure to follow the reasonable
instructions of the Board or such Grantee&rsquo;s direct supervisor, which failure, if curable, is not cured within 10 days after notice
to such Grantee or, if cured, recurs within 180 days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Code&rdquo; </I></B>means the Internal Revenue Code of 1986, as amended, or any successor statute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Committee&rdquo; </I></B>means the Compensation Committee of the Board or another committee appointed by the Board
to administer the Plan in accordance with Section 4(a) below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Common Stock&rdquo; </I></B>means the Company&rsquo;s voting common stock, $0.0001 par value per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Company&rdquo; </I></B>means Eyenovia, Inc., a Delaware corporation, or any successor entity that adopts the Plan
in connection with a Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Consultant&rdquo; </I></B>means any person (other than an Employee or a Director, solely with respect to rendering
services in such person&rsquo;s capacity as a Director) who is engaged by the Company or any Related Entity to render consulting or advisory
services to the Company or such Related Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Continuous Service&rdquo; </I></B>means that the provision of services to the Company or a Related Entity in any capacity
of Employee, Director or Consultant is not interrupted or terminated. In jurisdictions requiring notice in advance of an effective termination
as an Employee, Director or Consultant, Continuous Service shall be deemed terminated upon the actual cessation of providing services
to the Company or a Related Entity notwithstanding any required notice period that must be fulfilled before a termination as an Employee,
Director or Consultant can be effective under Applicable Laws. A Grantee&rsquo;s Continuous Service shall be deemed to have terminated
either upon an actual termination of Continuous Service or upon the entity for which the Grantee provides services ceasing to be a Related
Entity. Continuous Service shall not be considered interrupted in the case of (i) any approved leave of absence, (ii) transfers among
the Company, any Related Entity, or any successor in any capacity of Employee, Director or Consultant, or (iii) any change in status as
long as the individual remains in the service of the Company or a Related Entity in any capacity of Employee, Director or Consultant (except
as otherwise provided in the Award Agreement). An approved leave of absence for purposes of this Plan shall include sick leave, military
leave, or any other authorized personal leave, so long as the Company or Related Entity has a reasonable expectation that the individual
will return to provide services for the Company or Related Entity, and provided further that the leave does not exceed six months, unless
the individual has a statutory or contractual right to re-employment following a longer leave. For purposes of each Incentive Stock Option
granted under the Plan, if such leave exceeds three months, and reemployment upon expiration of such leave is not guaranteed by statute
or contract, then the Incentive Stock Option shall be treated as a Non-Qualified Stock Option beginning on the day three months and one
day following the expiration of such three month period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Corporate Transaction&rdquo; </I></B>means any of the following transactions, provided, however, that the Administrator
shall determine under parts (iv) and (v) whether multiple transactions are related, and its determination shall be final, binding and
conclusive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>a merger or consolidation in which the Company is not the surviving entity, except for a transaction the principal purpose of which
is to change the state in which the Company is incorporated;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the sale, transfer or other disposition of all or substantially all of the assets of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the complete liquidation or dissolution of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any reverse merger or series of related transactions culminating in a reverse merger (including, but not limited to, a tender offer
followed by a reverse merger) in which the Company is the surviving entity but (A) the Shares outstanding immediately prior to such merger
are converted or exchanged by virtue of the merger into other property, whether in the form of securities, cash or otherwise, or (B) in
which securities possessing more than 50% of the total combined voting power of the Company&rsquo;s outstanding securities are transferred
to a person or persons different from those who held such securities immediately prior to such merger or the initial transaction culminating
in such merger; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>acquisition in a single or series of related transactions by any person or related group of persons (other than the Company or
by a Company-sponsored employee benefit plan) of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities
possessing more than 50% of the total combined voting power of the Company&rsquo;s outstanding securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Data&rdquo; </I></B>has the meaning set forth in Section 22 of this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Director&rdquo; </I></B>means a member of the Board or the board of directors of any Related Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Disability&rdquo; </I></B>means a &ldquo;disability&rdquo; (or word of like import) as defined under the long-term
disability policy of the Company or the Related Entity to which the Grantee provides services regardless of whether the Grantee is covered
by such policy. If the Company or the Related Entity to which the Grantee provides service does not have a long-term disability plan in
place, &ldquo;Disability&rdquo; means that a Grantee is unable to carry out the responsibilities and functions of the position held by
the Grantee by reason of any medically determinable physical or mental impairment for a period of not less than 90 consecutive days. A
Grantee will not be considered to have incurred a Disability unless he or she furnishes proof of such impairment sufficient to satisfy
the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(r)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Disqualifying Disposition&rdquo; </I></B>means any disposition (including any sale) of Common Stock received upon
exercise of an Incentive Stock Option before either (i) two years after the date the Employee was granted the Incentive Stock Option,
or (ii) one year after the date the Employee acquired Common Stock by exercising the Incentive Stock Option. If the Employee has died
before such stock is sold, these holding period requirements do not apply and no Disqualifying Disposition can occur thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(s)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Dividend Equivalent Right&rdquo; </I></B>means a right entitling the Grantee to compensation measured by dividends
paid with respect to Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(t)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Effective Date&rdquo; </I></B>has the meaning set forth in Section 15 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(u)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Employee&rdquo; </I></B>means any person, including an Officer or Director, who is in the employ of the Company or
any Related Entity, subject to the control and direction of the Company or any Related Entity as to both the work to be performed and
the manner and method of performance. The payment of a director&rsquo;s fee by the Company or a Related Entity shall not be sufficient
to make such person an &ldquo;Employee&rdquo; of the Company or a Related Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Exchange Act&rdquo; </I></B>means the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(w)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Fair Market Value&rdquo; </I></B>means, as of any date, the value of the Common Stock determined as follows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If the Common Stock is listed on one or more established stock exchanges or national market systems, including without limitation
The NASDAQ Global Select Market, The NASDAQ Global Market, or The NASDAQ Capital Market of The NASDAQ Stock Market LLC, its Fair Market
Value shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on the principal exchange
or system on which the Common Stock is listed (as determined by the Administrator) on the date of determination (or, if no closing sales
price or closing bid was reported on that date, as applicable, on the last trading date such closing sales price or closing bid was reported),
as reported in The Wall Street Journal or such other source as the Administrator deems reliable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If the Common Stock is regularly quoted on an automated quotation system (including the OTC Bulletin Board) or by a recognized
securities dealer, its Fair Market Value shall be the closing sales price for such stock as quoted on such system or by such securities
dealer on the date of determination, but if selling prices are not reported, the Fair Market Value of a Share shall be the mean between
the high bid and low asked prices for the Common Stock on the date of determination (or, if no such prices were reported on that date,
on the last date such prices were reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>In the absence of an established market for the Common Stock of the type described in (i) and (ii), above, the Fair Market Value
thereof shall be determined by the Administrator in good faith by application of a reasonable valuation method consistently applied and
taking into consideration all available information material to the value of the Company in a manner in compliance with Section 409A,
or in the case of an Incentive Stock Option, in a manner in compliance with Section 422 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Grantee&rdquo; </I></B>means an Employee, Director or Consultant who receives an Award under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(y)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Incentive Stock Option&rdquo; </I></B>means an Option intended to qualify as an incentive stock option within the
meaning of Section 422 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(z)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Non-Qualified Stock Option&rdquo; </I></B>means an Option not intended to qualify as an Incentive Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(aa)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Officer&rdquo; </I></B>means a person who is an officer of the Company or a Related Entity within the meaning of Section
16 of the Exchange Act and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(bb)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Option&rdquo; </I></B>means an option to purchase one or more Shares pursuant to an Award Agreement granted under
the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(cc)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Parent&rdquo; </I></B>means
a &ldquo;parent corporation,&rdquo; whether now or hereafter existing, as defined in Section 424(e) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(dd)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Performance Period&rdquo; </I></B>means the time period during which specified performance criteria must be met in
connection with vesting of an Award as determined by the Administrator, as described in Section 6(d) below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(ee)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Plan&rdquo; </I></B>means this Eyenovia, Inc. Amended and Restated 2018 Omnibus Stock Incentive Plan, as the same
may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(ff)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Post-Termination Exercise Period&rdquo; </I></B>means the period specified in the Award Agreement of not less than
30 days commencing on the date of termination (other than termination by the Company or any Related Entity for Cause) of the Grantee&rsquo;s
Continuous Service, or such longer period as may be applicable upon death or Disability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(gg)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Related Entity&rdquo; </I></B>means any Parent or Subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(hh)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Restricted Stock&rdquo; </I></B>means Shares issued under the Plan to the Grantee for such consideration, if any,
and subject to such restrictions on transfer, rights of first refusal, repurchase provisions, forfeiture provisions, and other terms and
conditions as established by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> <B><I>&ldquo;Restricted Stock Units&rdquo; </I></B>means an Award which may be earned in whole or in part upon the passage of
time or the attainment of performance criteria established by the Administrator and which may be settled for cash, Shares or other securities
or a combination of cash, Shares or other securities as established by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(jj)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Rule 16b-3&rdquo; </I></B>means Rule 16b-3 promulgated under the Exchange Act or any successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(kk)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;SAR&rdquo; </I></B>means a stock appreciation right entitling the Grantee to Shares or cash compensation, as established
by the Administrator, measured by appreciation in the value of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(ll)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Section 409A&rdquo; </I></B>means Section 409A of the Code, the Treasury Regulations and other guidance issued thereunder
by the United States Department of the Treasury (whether issued before or after the Effective Date), and all state laws of similar effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(mm)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Share&rdquo; </I></B>means a share of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(nn)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Subsidiary&rdquo; </I></B>means a &ldquo;subsidiary corporation,&rdquo; whether now or hereafter existing, as defined
in Section 424(f) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(oo)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><I>&ldquo;Tax Obligations&rdquo; </I></B>means all income tax, social insurance, payroll tax, fringe benefits tax, or other
tax-related liabilities related to a Grantee&rsquo;s participation in the Plan and the receipt of any benefits hereunder, as determined
under the Applicable Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Stock Subject to the Plan</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Subject to adjustment as described in Section 13 below, the maximum aggregate number of Shares which may be issued pursuant to
all Awards (including Incentive Stock Options) is 5,700,000 Shares. The Shares may be authorized, but unissued, or reacquired Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Any Shares covered by an Award (or portion of an Award) which is forfeited, canceled or expires (whether voluntarily or involuntarily)
shall be deemed not to have been issued for purposes of determining the maximum aggregate number of Shares which may be issued under the
Plan, except that the maximum aggregate number of Shares which may be issued pursuant to the exercise of Incentive Stock Options shall
not exceed the number specified in Section 3(a). Shares that actually have been issued under the Plan pursuant to an Award shall not be
returned to the Plan and shall not become available for future issuance under the Plan, except that if unvested Shares are forfeited or
repurchased by the Company, such Shares shall become available for future grant under the Plan. In the event any Option or other Award
granted under the Plan is exercised through the tendering of Shares (either actually or through attestation), or in the event tax withholding
obligations are satisfied by tendering or withholding Shares, any Shares so tendered or withheld shall not again be available for Awards
under the Plan. To the extent that cash in lieu of Shares is delivered upon the exercise of an SAR pursuant to Section 6(1), the Company
shall be deemed, for purposes of applying the limitation on the number of shares, to have issued the number of Shares which it was entitled
to issue upon such exercise, notwithstanding that cash was issued in lieu of such Shares. Shares reacquired by the Company on the open
market or otherwise using cash proceeds from the exercise of Options shall not be available for Awards under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Administration of the Plan</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Plan Administrator</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Administration with Respect to Directors and Officers</U>. With respect to grants of Awards to Directors or Employees who are
also Officers or Directors of the Company, the Plan shall be administered by (A) the Board or (B) a Committee designated by the Board,
which Committee shall be constituted in such a manner as to satisfy the Applicable Laws and to permit such grants and related transactions
under the Plan to be exempt from Section 16(b) of the Exchange Act in accordance with Rule 16b-3. Once appointed, such Committee shall
continue to serve in its designated capacity until otherwise directed by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Administration With Respect to Consultants and Other Employees</U>. With respect to grants of Awards to Employees or Consultants
who are neither Directors nor Officers of the Company, the Plan shall be administered by (A) the Board or (B) a Committee designated by
the Board, which Committee shall be constituted in such a manner as to satisfy the Applicable Laws and may or may not be composed of members
of the Board. Once appointed, such Committee shall continue to serve in its designated capacity until otherwise directed by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Multiple Administrative Bodies</U>. The Plan may be administered by different bodies with respect to Directors, Officers, Consultants,
and Employees who are neither Directors nor Officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Powers of the Administrator</U>. Subject to Applicable Laws and the provisions of the Plan (including any other powers given
to the Administrator hereunder), and except as otherwise provided by the Board, the Administrator shall have the authority, in its discretion:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>to select the Employees, Directors and Consultants to whom Awards may be granted from time to time hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>to determine whether and to what extent Awards are granted hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT>to determine the number of Shares or the amount of other consideration to be covered by each Award granted hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT>determine the vesting schedule applicable to all Awards under the Plan, provided, however, that in any event the minimum vesting
period for all Awards granted under the Plan after the Effective Date will be at least 12 months from the applicable date of grant such
that no portion of any such Award will vest or become exercisable prior to the first anniversary of the date of grant of such Award;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>to determine the type, terms and conditions of any Award granted hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT>to accelerate vesting on any Award or to waive any forfeiture restrictions applicable thereto (notwithstanding the minimum vesting
requirement set forth in Section 2(c)(iv) above), or to waive any other limitation or restriction with respect to an Award;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT>to approve forms of Award Agreements for use under the Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT>to establish additional terms, conditions, rules or procedures to accommodate the rules or laws of applicable non-U.S. jurisdictions
and to afford Grantees favorable treatment under such rules or laws; provided, however, that no Award shall be granted under any such
additional terms, conditions, rules or procedures with terms or conditions which are inconsistent with the provisions of the Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>to amend the terms of any outstanding Award granted under the Plan, provided that any amendment that would adversely affect the
Grantee&rsquo;s rights under an outstanding Award shall not be made without the Grantee&rsquo;s written consent; provided, however, that
an amendment or modification that may cause an Incentive Stock Option to become a Non-Qualified Stock Option shall not be treated as adversely
affecting the rights of the Grantee;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>to construe and interpret the terms of the Plan and Awards, including without limitation, any notice of Award or Award Agreement,
granted pursuant to the Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(xi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>to institute an option exchange program;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(xii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>to make other determinations as provided in this Plan; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(xiii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT>to take such other action, not inconsistent with the terms of the Plan, as the Administrator deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0">The express grant in the Plan of any specific power to the
Administrator shall not be construed as limiting any power or authority of the Administrator; provided that the Administrator may not
exercise any right or power reserved to the Board. Any decision made, or action taken, by the Administrator or in connection with the
administration of this Plan shall be final, conclusive and binding on all persons having an interest in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Indemnification</U>. In addition to such other rights of indemnification as they may have as members of the Board or as Officers
or Employees of the Company or a Related Entity, members of the Board and any Officers or Employees of the Company or a Related Entity
to whom authority to act for the Board, the Administrator or the Company is delegated shall be defended and indemnified by the Company
to the extent permitted by law on an after-tax basis against all reasonable expenses, including attorneys&rsquo; fees, actually and necessarily
incurred in connection with the defense of any claim, investigation, action, suit or proceeding, or in connection with any appeal therein,
to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with the Plan, or any
Award granted hereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved by the Company)
or paid by them in satisfaction of a judgment in any such claim, investigation, action, suit or proceeding, except in relation to such
liabilities, costs, and expenses as may arise out of, or result from, the bad faith, gross negligence, willful misconduct, or criminal
acts of such persons; provided, however, that within 30 days after the institution of such claim, investigation, action, suit or proceeding,
such person shall offer to the Company, in writing, the opportunity at the Company&rsquo;s expense to defend the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Eligibility</U>. Awards other than Incentive Stock Options may be granted to Employees, Directors, and Consultants of the Company
or any Related Entity. Incentive Stock Options may be granted only to Employees of the Company or a Related Entity. An Employee, Director,
or Consultant who has been granted an Award may, if otherwise eligible, be granted additional Awards. Awards may be granted to such Employees,
Directors, or Consultants who are residing in non-U.S. jurisdictions as the Administrator may determine from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Terms and Conditions of Awards</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Types of Awards</U>. The Administrator is authorized under the Plan to award any type of arrangement to an Employee, Director
or Consultant that is not inconsistent with the provisions of the Plan and that by its terms involves or might involve the issuance of
(i) Shares, (ii) cash or (iii) an Option, an SAR, or similar right with a fixed or variable price related to the Fair Market Value of
the Shares and with an exercise or conversion privilege related to the passage of time, the occurrence of one or more events, or the satisfaction
of performance criteria or other conditions. Such Awards include, without limitation, Options, SARs, sales or bonuses of Restricted Stock,
Restricted Stock Units, and Dividend Equivalent Rights. An Award may consist of one such security or benefit, or two or more of them in
any combination or alternative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Designation of Award</U>. Each Award shall be evidenced by an Award Agreement in form and substance satisfactory to the Administrator.
The type of each Award shall be designated in the Award Agreement. In the case of an Option, the Option shall be designated as either
an Incentive Stock Option or a Non-Qualified Stock Option. However, notwithstanding such designation, any portion of an Option designated
as an Incentive Stock Option that exceeds the $100,000 limitation of Section 422(d) of the Code will be treated as a Non-Qualified Stock
Option. The $100,000 limitation of Section 422(d) of the Code is calculated based on the aggregate Fair Market Value of the Shares subject
to Options designated as Incentive Stock Options which become exercisable for the first time by a Grantee during any calendar year (under
all plans of the Company or any Related Entity). For purposes of this calculation, Incentive Stock Options shall be taken into account
in the order in which they were granted, and the Fair Market Value of the Shares shall be determined as of the grant date of the relevant
Option. Any Option granted which fails to satisfy the requirements of the Applicable Laws for treatment as an Incentive Stock Option shall
be a Non-Qualified Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Conditions of Award</U>. Subject to the terms of the Plan, the Administrator shall determine the provisions, terms, and conditions
of each Award including, but not limited to, the Award vesting schedule (subject to the limitation set forth in Section 2(c)(iv) above),
repurchase provisions, rights of first refusal, forfeiture provisions, form of payment (cash, Shares, or other consideration) upon settlement
of the Award, payment contingencies, and satisfaction of any performance criteria that may be established by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Performance-Based Awards</U>. The Administrator may include in an Award provisions such that the vesting or other realization
of an Award by a Grantee will be subject to the achievement of certain performance criteria as the Administrator may determine over the
course of a Performance Period determined by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The performance criteria will be established by the Administrator and may include any one of, or combination of, the following
criteria:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(A)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Net earnings or net income (before or after taxes);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(B)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Earnings per share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(C)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Net sales growth;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(D)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Net operating profit;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(E)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Return measures (including, but not limited to, return on assets, capital, equity, or sales);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(F)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Cash flow (including, but not limited to, operating cash flow, free cash flow, and cash flow return on capital);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(G)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Cash flow per share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(H)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Earnings before or after taxes, interest, depreciation, and/or amortization;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(I)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Gross or operating margins;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(J)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Productivity ratios;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(K)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Share price (including, but not limited to, growth measures and total stockholder return);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(L)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Expense targets or ratios;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(M)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Charge-off levels;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(N)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Improvement in or attainment of revenue levels;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(O)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Margins;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(P)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Operating efficiency;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(Q)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Operating expenses;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(R)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Economic value added;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(S)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Improvement in or attainment of expense levels;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(T)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Improvement in or attainment of working capital levels;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(U)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Debt reduction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(V)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Capital targets;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(W)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Regulatory, clinical or manufacturing milestones; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(X)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Consummation of acquisitions, dispositions, projects or other specific events or transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Performance criteria may be measured on an absolute (e.g., plan or budget) or relative basis, and may be established on a corporate-wide
basis or with respect to one or more business units, divisions, subsidiaries or business segments, or may be established on an individual
basis. Relative performance may be measured against a group of peer companies, a financial market index or other acceptable objective
and quantifiable indices. If the Administrator determines that a change in the business, operations, corporate structure or capital structure
of the Company, or the manner in which the Company conducts its business, or other events or circumstances render the performance objectives
unsuitable, the Administrator may modify the minimum acceptable level of achievement, in whole or in part, as the Administrator deems
appropriate and equitable. Performance objectives may be adjusted for material items not originally contemplated in establishing the performance
target for items resulting from discontinued operations, extraordinary gains and losses, the effect of changes in accounting standards
or principles, acquisitions or divestitures, changes in tax rules or regulations, capital transactions, restructuring, nonrecurring gains
or losses or unusual items. Performance measures may vary from Award to Award, and from Grantee to Grantee, and may be established on
a standalone basis, in tandem or in the alternative. The Administrator will have the authority to impose such other restrictions on as
it may deem necessary or appropriate to ensure that performance-based Awards under this Section 6(d) satisfy all requirements of the Applicable
Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Before the 90th day of the applicable Performance Period (or, if the Performance Period is less than one year, no later than the
number of days which is equal to 25% of such Performance Period), the Administrator will determine the duration of the Performance Period,
the performance criteria on which performance will be measured, and the amount and terms of payment/vesting upon achievement of the such
criteria.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Following the completion of each Performance Period, the Administrator will certify in writing whether the applicable performance
criteria have been achieved for the Awards for such Performance Period. A Grantee will be eligible to receive payment pursuant to an Award
for a Performance Period only if the performance criteria for such Performance Period are achieved. In determining the amounts earned
by a Grantee pursuant to an Award issued pursuant to this Section 6(d), the Administrator will have the right to (A) reduce or eliminate
(but not to increase) the amount payable at a given level of performance to take into account additional factors that the Administrator
may deem relevant to the assessment of individual or corporate performance for the Performance Period, (B) determine what actual Award,
if any, will be paid in the event of a Corporate Transaction or in the event of a termination of employment following a Corporate Transaction
prior to the end of the Performance Period, and (C) determine what actual Award, if any, will be paid in the event of a termination of
employment other than as the result of a Grantee&rsquo;s death or Disability prior to a Corporate Transaction and prior to the end of
the Performance Period to the extent an actual Award would have otherwise been achieved had the Grantee remained employed through the
end of the Performance Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Payment of the Award to a Grantee shall be paid following the end of the Performance Period, or if later, the date on which any
applicable contingency or restriction has ended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Acquisitions and Other Transactions</U>. The Administrator may issue Awards under the Plan in settlement, assumption or substitution
for, outstanding awards or obligations to grant future awards in connection with the Company or a Related Entity acquiring another entity,
an interest in another entity or an additional interest in a Related Entity whether by merger, stock purchase, asset purchase or other
form of transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Deferral of Award Payment</U>. The Administrator may establish one or more programs under the Plan to permit selected Grantees
the opportunity to elect to defer receipt of consideration upon exercise of an Award, satisfaction of performance criteria, or other event
that absent the election would entitle the Grantee to payment or receipt of Shares or other consideration under an Award. The Administrator
may establish the election procedures, the timing of such elections, the mechanisms for payments of, and accrual of interest or other
earnings, if any, on amounts, Shares or other consideration so deferred, and such other terms, conditions, rules and procedures that the
Administrator deems advisable for the administration of any such deferral program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Separate Programs</U>. The Administrator may establish one or more separate programs under the Plan for the purpose of issuing
particular forms of Awards to one or more classes of Grantees on such terms and conditions as determined by the Administrator from time
to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Early Exercise</U>. An Award Agreement may, but need not, include a provision whereby the Grantee may elect at any time while
an Employee, Director or Consultant to exercise any part or all of the Award prior to full vesting of the Award. Any unvested Shares received
pursuant to such exercise may be subject to a repurchase right in favor of the Company or a Related Entity or to any other restriction
the Administrator determines to be appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Term of Award</U>. The term of each Award shall be the term stated in the Award Agreement, provided, however, that the term
shall be no more than 10 years from the date of grant thereof. However, in the case of an Incentive Stock Option granted to a Grantee
who, at the time the Option is granted, owns stock representing more than 10% of the voting power of all classes of stock of the Company
or any Related Entity, the term of the Incentive Stock Option shall be five years from the date of grant thereof or such shorter term
as may be provided in the Award Agreement. Notwithstanding the foregoing, the specified term of any Award shall not include any period
for which the Grantee has elected to defer the receipt of the Shares or cash issuable pursuant to the Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Transferability of Awards</U>. Unless the Administrator provides otherwise, no Award may be sold, pledged, assigned, hypothecated,
transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the
lifetime of the Grantee, only by the Grantee. Notwithstanding the foregoing, the Grantee may designate one or more beneficiaries of the
Grantee&rsquo;s Award in the event of the Grantee&rsquo;s death on a beneficiary designation form provided by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Time of Granting Awards</U>. The date of grant of an Award shall for all purposes be the date on which the Administrator makes
the determination to grant such Award, or such other later date as is determined by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Stock Appreciation Rights</U>. An SAR may be granted (i) with respect to any Option granted under this Plan, either concurrently
with the grant of such Option or at such later time as determined by the Administrator (as to all or any portion of the Shares subject
to the Option), or (ii) alone, without reference to any related Option. Each SAR granted by the Administrator under this Plan shall be
subject to the following terms and conditions. Each SAR granted to any Grantee shall relate to such number of Shares as shall be determined
by the Administrator, subject to adjustment as provided in Section 13. In the case of an SAR granted with respect to an Option, the number
of Shares to which the SAR pertains shall be reduced in the same proportion that the holder of the Option exercises the related Option.
The exercise price of an SAR will be determined by the Administrator at the date of grant but may not be less than 100% of the Fair Market
Value of the Shares subject thereto on the date of grant. Subject to the right of the Administrator to deliver cash in lieu of Shares
(which, as it pertains to Officers and Directors of the Company, shall comply with all requirements of the Exchange Act), the number of
Shares which shall be issuable upon the exercise of an SAR shall be determined by dividing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the number of Shares as to which the SAR is exercised multiplied by the amount of the appreciation in such Shares (for this purpose,
the &ldquo;appreciation&rdquo; shall be the amount by which the Fair Market Value of the Shares subject to the SAR on the exercise date
exceeds (A) in the case of an SAR related to an Option, the exercise price of the Shares under the Option or (B) in the case of an SAR
granted alone, without reference to a related Option, an amount which shall be determined by the Administrator at the time of grant, subject
to adjustment under Section 13); by</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the Fair Market Value of a Share on the exercise date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 1in">In lieu of issuing Shares upon the exercise of an SAR,
the Administrator may elect to pay the holder of the SAR cash equal to the Fair Market Value on the exercise date of any or all of the
Shares which would otherwise be issuable. No fractional Shares shall be issued upon the exercise of an SAR; instead, the holder of the
SAR shall be entitled to receive a cash adjustment equal to the same fraction of the Fair Market Value of a Share on the exercise date
or to purchase the portion necessary to make a whole share at its Fair Market Value on the date of exercise. The exercise of an SAR related
to an Option shall be permitted only to the extent that the Option is exercisable under Section 11 on the date of surrender. Any Incentive
Stock Option surrendered pursuant to the provisions of this Section 6(1) shall be deemed to have been converted into a Non-Qualified Stock
Option immediately prior to such surrender.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Non-Employee Director Award Limits</U>. The maximum number of Shares subject to Awards granted during a single fiscal year to
any non-employee Director, taken together with any cash fees paid during the fiscal year to the non-employee Director, in respect of the
Director&rsquo;s service as a member of the Board during such year (including service as a member or chair of any committees of the Board),
will not exceed $150,000 in total value (calculating the value of any such Awards based on the grant date fair value of such Awards for
financial reporting purposes). The independent members of the Board may make exceptions to this limit for a non-executive chair of the
Board, provided that the non-employee Director receiving such additional compensation may not participate in the decision to award such
compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Award Exercise or Purchase Price, Consideration and Taxes</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Exercise or Purchase Price</U>. The exercise or purchase price, if any, for an Award shall be as follows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>In the case of an Incentive Stock Option:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT>granted to an Employee who, at the time of the grant of such Incentive Stock Option owns stock representing more than 10% of the
voting power of all classes of stock of the Company or any Related Entity, the per Share exercise price shall be not less than 110% of
the Fair Market Value per Share on the date of grant; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT>granted to any Employee other than an Employee described in the preceding paragraph, the per Share exercise price shall be not
less than 100% of the Fair Market Value per Share on the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>In the case of a Non-Qualified Stock Option, the per Share exercise price shall be not less than 100% of the Fair Market Value
per Share on the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>In the case of other Awards, such price as is determined by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Notwithstanding the foregoing provisions of this Section 7(a), in the case of an Award issued pursuant to Section 6(e), above,
the exercise or purchase price for the Award shall be determined in accordance with the provisions of the relevant instrument evidencing
the agreement to issue such Award and the Applicable Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Consideration</U>. Subject to Applicable Laws, the consideration to be paid for the Shares to be issued upon exercise or purchase
of an Award, including the method of payment, shall be determined by the Administrator. In addition to any other types of consideration
the Administrator may determine, the Administrator is authorized to accept as consideration for Shares issued under the Plan the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>cash;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>check;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>surrender of Shares or delivery of a properly executed form of attestation of ownership of Shares as the Administrator may require
which have a Fair Market Value on the date of surrender or attestation equal to the aggregate exercise price of the Shares as to which
said Award shall be exercised;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>with respect to Options, payment through a broker-dealer sale and remittance procedure pursuant to which the Grantee (A) shall
provide written instructions to a broker-dealer acceptable to the Company to effect the immediate sale of some or all of the purchased
Shares and remit to the Company sufficient funds to cover the aggregate exercise price payable for the purchased Shares and (B) shall
provide written directives to the Company to deliver the certificates (or other evidence satisfactory to the Company to the extent that
the Shares are uncertificated) for the purchased Shares directly to such broker-dealer in order to complete the sale transaction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>with respect to Options, payment through a &ldquo;net exercise&rdquo; such that, without the payment of any funds, the Grantee
may exercise the Option and receive the net number of Shares equal to (i) the number of Shares as to which the Option is being exercised,
multiplied by (ii) a fraction, the numerator of which is the Fair Market Value per Share (on such date as is determined by the Administrator)
less the Exercise Price per Share, and the denominator of which is such Fair Market Value per Share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>past or future services actually or to be rendered to the Company or a Related Entity; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any combination of the foregoing methods of payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">The Administrator may at any time or from time to time, by
adoption of or by amendment to the standard forms of Award Agreement described in Section 4(c)(vii), or by other means, grant Awards which
do not permit all of the foregoing forms of consideration to be used in payment for the Shares or which otherwise restrict one or more
forms of consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notice to Company of Disqualifying Disposition</U>. Each Employee who receives an Incentive Stock Option must agree to notify
the Company in writing immediately after the Employee makes a Disqualifying Disposition of any Common Stock acquired pursuant to the exercise
of an Incentive Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Tax Withholding</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Prior to the delivery of any Shares or cash pursuant to an Award (or the exercise thereof), or at such other time as the Tax Obligations
are due, the Company, in accordance with the Code and any Applicable Laws, shall have the power and the right to deduct or withhold, or
require a Grantee to remit to the Company, an amount sufficient to satisfy all Tax Obligations. The Administrator may condition such delivery,
payment, or other event pursuant to an Award on the payment by the Grantee of any such Tax Obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The Administrator, pursuant to such procedures as it may specify from time to time, may designate the method or methods by which
a Grantee may satisfy the Tax Obligations. As determined by the Administrator from time to time, these methods may include one or more
of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>paying cash;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>electing to have the Company withhold cash or Shares deliverable to the Grantee having a Fair Market Value equal to the amount
required to be withheld;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>delivering to the Company already-owned Shares having a Fair Market Value equal to the amount required to be withheld or remitted,
provided the delivery of such Shares will not result in any adverse accounting consequences as the Administrator determines;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>selling a sufficient number of Shares otherwise deliverable to the Grantee through such means as the Administrator may determine
(whether through a broker or otherwise) equal to the Tax Obligations required to be withheld;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>retaining from salary or other amounts payable to the Grantee cash having a sufficient value to satisfy the Tax Obligations; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any other means which the Administrator determines to both comply with Applicable Laws, and to be consistent with the purposes
of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">The amount of Tax Obligations will be deemed to include any
amount that the Administrator determines may be withheld at the time the election is made, not to exceed the amount determined by using
the maximum federal, state, local and foreign marginal income tax rates applicable to the Grantee or the Company, as applicable, with
respect to the Award on the date that the amount of tax or social insurance liability to be withheld or remitted is to be determined.
The Fair Market Value of the Shares to be withheld or delivered shall be determined as of the date that the Tax Obligations are required
to be withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Rights As a Stockholder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Restricted Stock</U>. Except as otherwise provided in any Award Agreement, a Grantee will not have any rights of a stockholder
with respect to any of the Shares granted to the Grantee under an Award of Restricted Stock (including the right to vote or receive dividends
and other distributions paid or made with respect thereto). No dividends or Dividend Equivalent Rights will be paid in respect of any
unvested Award of Restricted Stock, unless and until such Shares vest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Other Awards</U>. In the case of Awards other than Restricted Stock, a Grantee will not have any rights of a stockholder, nor
will dividends or Dividend Equivalent Rights accrue or be paid, with respect to any of the Shares granted pursuant to such Award until
the Award is exercised or settled and the Shares are delivered (as evidenced by the appropriate entry on the books of the Company or of
a duly authorized transfer agent of the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Exercise of Award</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Procedure for Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Any Award granted hereunder shall be exercisable at such times and under such conditions as determined by the Administrator under
the terms of the Plan and as specified in the Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>An Award shall be deemed to be exercised when written notice of such exercise has been given to the Company in accordance with
the terms of the Award by the person entitled to exercise the Award and full payment for the Shares with respect to which the Award is
exercised has been made, including, to the extent selected, use of the broker-dealer sale and remittance procedure to pay the purchase
price as provided in Section 7(b)(iv).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Exercise of Award Following Termination of Continuous Service</U>. In the event of termination of a Grantee&rsquo;s Continuous
Service for any reason other than Disability or death, such Grantee may, but only during the Post-Termination Exercise Period (but in
no event later than the expiration date of the term of such Award as set forth in the Award Agreement), exercise the portion of the Grantee&rsquo;s
Award that was vested at the date of such termination or such other portion of the Grantee&rsquo;s Award as may be determined by the Administrator.
The Grantee&rsquo;s Award Agreement may provide that upon the termination of the Grantee&rsquo;s Continuous Service for Cause, the Grantee&rsquo;s
right to exercise the Award shall terminate concurrently with the termination of Grantee&rsquo;s Continuous Service. In the event of a
Grantee&rsquo;s change of status from Employee to Consultant, an Employee&rsquo;s Incentive Stock Option shall convert automatically to
a Non-Qualified Stock Option on the day three months and one day following such change of status. To the extent that the Grantee&rsquo;s
Award was unvested at the date of termination, or if the Grantee does not exercise the vested portion of the Grantee&rsquo;s Award within
the Post-Termination Exercise Period, the Award shall terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Disability of Grantee</U>. In the event of termination of a Grantee&rsquo;s Continuous Service as a result of his or her Disability,
such Grantee may, but only within 12 months from the date of such termination (or such longer period as specified in the Award Agreement
but in no event later than the expiration date of the term of such Award as set forth in the Award Agreement), exercise the portion of
the Grantee&rsquo;s Award that was vested at the date of such termination; provided, however, that if such Disability is not a &ldquo;disability&rdquo;
as such term is defined in Section 22(e)(3) of the Code, in the case of an Incentive Stock Option such Incentive Stock Option shall automatically
convert to a Non-Qualified Stock Option on the day three months and one day following such termination. To the extent that the Grantee&rsquo;s
Award was unvested at the date of termination, or if Grantee does not exercise the vested portion of the Grantee&rsquo;s Award within
the time specified herein, the Award shall terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Death of Grantee</U>. In the event of a termination of the Grantee&rsquo;s Continuous Service as a result of his or her death,
or in the event of the death of the Grantee during the Post-Termination Exercise Period or during the 12 month period following the Grantee&rsquo;s
termination of Continuous Service as a result of his or her Disability, the Grantee&rsquo;s estate or a person who acquired the right
to exercise the Award by bequest or inheritance may exercise the portion of the Grantee&rsquo;s Award that was vested as of the date of
termination, within 12 months from the date of death (or such longer period as specified in the Award Agreement but in no event later
than the expiration of the term of such Award as set forth in the Award Agreement). To the extent that, at the time of death, the Grantee&rsquo;s
Award was unvested, or if the Grantee&rsquo;s estate or a person who acquired the right to exercise the Award by bequest or inheritance
does not exercise the vested portion of the Grantee&rsquo;s Award within the time specified herein, the Award shall terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Extension if Exercise Prevented by Law</U>. Notwithstanding the foregoing, if the exercise of an Award within the applicable
time periods set forth in this Section 11 is prevented by the provisions of Section 12 below, the Award shall remain exercisable until
one month after the date the Grantee is notified by the Company that the Award is exercisable, but in any event no later than the expiration
of the term of such Award as set forth in the Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Conditions Upon Issuance of Shares; Manner of Issuance of Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If at any time the Administrator determines that the delivery of Shares pursuant to the exercise, vesting or any other provision
of an Award is or may be unlawful under Applicable Laws, the vesting or right to exercise an Award or to otherwise receive Shares pursuant
to the terms of an Award shall be suspended until the Administrator determines that such delivery is lawful and shall be further subject
to the approval of counsel for the Company with respect to such compliance. The Company shall have no obligation to effect any registration
or qualification of the Shares under any Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As a condition to the exercise of an Award, the Company may require the person exercising such Award to represent and warrant at
the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute
such Shares if, in the opinion of counsel for the Company, such a representation is required by any Applicable Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Subject to the Applicable Laws and any governing rules or regulations, the Company shall issue or cause to be issued the Shares
acquired pursuant to an Award and shall deliver such Shares to or for the benefit of the Grantee by means of one or more of the following
as determined by the Administrator: (i) by delivering to the Grantee evidence of book entry Shares credited to the account of the Grantee,
(ii) by depositing such Shares for the benefit of the Grantee with any broker with which the Grantee has an account relationship, or (iii)
by delivering such Shares to the Grantee in certificate form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>No fractional Shares shall be issued pursuant to any Award under the Plan; any Grantee who would otherwise be entitled to receive
a fraction of a Share upon exercise or vesting of an Award will receive from the Company cash in lieu of such fractional Shares in an
amount equal to the Fair Market Value of such fractional Shares, as determined by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Adjustments</U>. Subject to any required action by the stockholders of the Company, the number of Shares covered by each outstanding
Award, and the number of Shares which have been authorized for issuance under the Plan but as to which no Awards have yet been granted
or which have been returned to the Plan, the exercise or purchase price of each such outstanding Award, as well as any other terms that
the Administrator determines require adjustment shall be proportionately adjusted for (i) any increase or decrease in the number of issued
and outstanding Shares resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Shares,
or similar transaction affecting the Shares, (ii) any other increase or decrease in the number of issued and outstanding Shares effected
without receipt of consideration by the Company, or (iii) any other transaction with respect to the Company&rsquo;s Common Stock including
a corporate merger, consolidation, acquisition of property or stock, separation (including a spin-off or other distribution of stock or
property), reorganization, liquidation (whether partial or complete) or any similar transaction; provided, however that conversion of
any convertible securities of the Company shall not be deemed to have been &ldquo;effected without receipt of consideration.&rdquo; Such
adjustment shall be made by the Administrator and its determination shall be final, binding and conclusive. Except as the Administrator
determines, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall
affect, and no adjustment by reason hereof shall be made with respect to, the number or price of Shares subject to an Award. No adjustments
shall be made for dividends paid in cash or in property other than Common Stock of the Company, nor shall cash dividends or dividend equivalents
accrue or be paid in respect of unexercised Options or unvested Awards hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Corporate Transactions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Termination of Award to Extent Not Assumed in Corporate Transaction</U>. Effective upon the consummation of a Corporate Transaction,
all outstanding Awards under the Plan shall terminate. However, all such Awards shall not terminate to the extent they are assumed in
connection with the Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Acceleration of Award Upon Corporate Transaction</U>. The Administrator shall have the authority, exercisable either in advance
of any actual or anticipated Corporate Transaction or at the time of an actual Corporate Transaction, and exercisable at the time of the
grant of an Award under the Plan or any time while an Award remains outstanding, to provide for the full or partial automatic vesting
and exercisability of one or more outstanding unvested Awards under the Plan and the release from restrictions on transfer and repurchase
or forfeiture rights of such Awards in connection with a Corporate Transaction on such terms and conditions as the Administrator may specify.
The Administrator also shall have the authority to condition any such Award vesting and exercisability or release from such limitations
upon the subsequent termination of the Continuous Service of the Grantee within a specified period following the effective date of the
Corporate Transaction. The Administrator may provide that any Awards so vested or released from such limitations in connection with a
Corporate Transaction shall remain fully exercisable until the expiration or sooner termination of the Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Effect of Acceleration on Incentive Stock Options</U>. Any Incentive Stock Option accelerated under this Section 14 in connection
with a Corporate Transaction shall remain exercisable as an Incentive Stock Option under the Code only to the extent the $100,000 limitation
of Section 422(d) of the Code is not exceeded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Effective Date and Term of Plan</U>. This Plan was initially adopted by the Board on March 6, 2018 and was approved by the stockholders
of the Company on June 11, 2018. A subsequent amendment to the Plan was adopted by the Board on April 5, 2019 and was approved by the
stockholders of the Company on June 11, 2019. The Board approved the current Plan, as amended and restated, on April 7, 2020 and the same
was approved by the stockholders of the Company on June 30, 2020. The Board approved a subsequent amendment to the Plan on March 31, 2021
(the <B><I>&ldquo;Effective Date&rdquo;). </I></B>The Plan shall continue in effect for a period of 10 years from the Effective Date unless
sooner terminated. The expiration of the Plan will not have the effect of terminating any Awards outstanding on such date, except as otherwise
provided in the applicable Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Amendment, Suspension or Termination of the Plan</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The Board may at any time suspend or terminate the Plan, or amend the Plan in any respect, except that it may not, without the
approval of the stockholders obtained within 12 months before or after the Board adopts a resolution authorizing any of the following
actions, do any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>increase the total number of shares that may be issued under the Plan (except by adjustment pursuant to Section 13);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>modify the provisions of Section 6 regarding eligibility for grants of Incentive Stock Options;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>modify the provisions of Section 7(a) regarding the exercise price at which shares may be offered pursuant to Options (except by
adjustment pursuant to Section 13);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>extend the expiration date of the Plan; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>except as provided in Section 13 (including, without limitation, any stock dividend, stock split, extraordinary cash dividend,
recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination, or exchange of shares), the Company may not
amend an Award granted under the Plan to reduce its exercise price per share, cancel and regrant new Awards with lower prices per share
than the original prices per share of the cancelled Awards, or cancel any Awards in exchange for cash or the grant of replacement Awards
with an exercise price that is less than the exercise price of the original Awards, essentially having the effect of a repricing, without
approval by the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>No Award may be granted during any suspension of the Plan or after termination of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>No suspension or termination of the Plan shall adversely affect any rights under Awards already granted to a Grantee without his
or her consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">17.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Reservation of Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The Company, during the term of the Plan, will at all times reserve and keep available such number of Shares as shall be sufficient
to satisfy the requirements of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the
Company&rsquo;s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability
in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">18.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No Effect on Terms of Employment/Consulting Relationship</U>. The Plan shall not confer upon any Grantee any right with respect
to the Grantee&rsquo;s Continuous Service, nor shall it interfere in any way with his or her right or the right of the Company or a Related
Entity to terminate the Grantee&rsquo;s Continuous Service at any time, with or without Cause, and with or without notice. The ability
of the Company or any Related Entity to terminate the employment of a Grantee who is employed at will is in no way affected by its determination
that the Grantee&rsquo;s Continuous Service has been terminated for Cause for the purposes of this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">19.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No Effect on Retirement and Other Benefit Plans</U>. Except as specifically provided in a retirement or other benefit plan of
the Company or a Related Entity, Awards shall not be deemed compensation for purposes of computing benefits or contributions under any
retirement plan of the Company or a Related Entity, and shall not affect any benefits under any other benefit plan of any kind or any
benefit plan subsequently instituted under which the availability or amount of benefits is related to level of compensation. The Plan
is not a &ldquo;Retirement Plan&rdquo; or &ldquo;Welfare Plan&rdquo; under the Employee Retirement Income Security Act of 1974, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">20.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Information to Grantees</U>. The Company shall provide to each Grantee, during the period for which such Grantee has one or
more Awards outstanding, such information as required by Applicable Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">21.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Electronic Delivery</U>. The Administrator may decide to deliver any documents related to any Award granted under the Plan through
an online or electronic system established and maintained by the Company or another third party designated by the Company or to request
a Grantee&rsquo;s consent to participate in the Plan by electronic means. By accepting an Award, each Grantee consents to receive such
documents by electronic delivery and agrees to participate in the Plan through an online or electronic system established and maintained
by the Company or another third party designated by the Company, and such consent shall remain in effect throughout Grantee&rsquo;s Continuous
Service with the Company and any Related Entity and thereafter until withdrawn in writing by Grantee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">22.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Data Privacy</U>. The Administrator may decide to collect, use and transfer, in electronic or other form, personal data as described
in this Plan or any Award for the exclusive purpose of implementing, administering and managing participation in the Plan. By accepting
an Award, each Grantee acknowledges that the Company holds certain personal information about Grantee, including, but not limited to,
name, home address and telephone number, date of birth, social security number or other identification number, salary, nationality, job
title, details of all Awards awarded, cancelled, exercised, vested or unvested, for the purpose of implementing, administering and managing
the Plan (the <B><I>&ldquo;Data&rdquo;). </I></B>Each Grantee further acknowledges that Data may be transferred to any third parties assisting
in the implementation, administration and management of the Plan and that these third parties may be located in jurisdictions that may
have different data privacy laws and protections, and Grantee authorizes such third parties to receive, possess, use, retain and transfer
the Data, in electronic or other form, for the purposes of implementing, administering and managing the Plan, including any requisite
transfer of such Data as may be required to a broker or other third party with whom the recipient or the Company may elect to deposit
any Shares acquired upon any Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">23.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Application of Section 409A</U>. This Plan and Awards granted hereunder are intended to comply with the requirements of Section
409A, to the extent applicable. All Awards will be construed and administered such that the Award either qualifies for an exemption from
the requirements of Section 409A or satisfies the requirements of Section 409A. If an Award is subject to Section 409A: (i) distributions
will only be made in a manner and upon an event permitted under Section 409A, (ii) payments to be made upon a termination of employment
will only be made upon a &ldquo;separation from service&rdquo; under Section 409A, (iii) payments to be made upon a Corporate Transaction
will only be made upon a &ldquo;change of control event&rdquo; under Section 409A, and (iv) in no event will a Grantee, directly or indirectly,
designate the calendar year in which a distribution is made, except in accordance with Section 409A. Each payment in any series of installment
payments under an Award will be treated as a separate payment for purposes of Section 409A. Any Award granted under this Plan that is
subject to Section 409A and that is to be distributed to a &ldquo;specified employee&rdquo; (as defined in Section 409A) upon a separation
from service will be administered so that any distribution with respect to such Award will be postponed for six months following the date
of the Grantee&rsquo;s separation from service, if required by Section 409A. If a distribution is so delayed pursuant to Section 409A,
the distribution will be paid within 30 days after the end of the six-month period or the Grantee&rsquo;s death, if earlier. Notwithstanding
any provision of the Plan to the contrary, in the event that following the Effective Date the Administrator determines that any Award
may be subject to Section 409A, the Administrator may adopt such amendments to the Plan and the applicable Award Agreement or adopt other
policies and procedures, or take any other actions, that the Administrator determines are necessary or appropriate to (A) exempt the Award
from Section 409A and/or preserve the intended tax treatment of the benefits provided with respect to the Award, or (B) comply with the
requirements of Section 409A. Notwithstanding anything in the Plan or any Award Agreement to the contrary, each Grantee will be solely
responsible for the tax consequences of Awards, and in no event will the Company have any responsibility or liability if an Award does
not meet any applicable requirements of Section 409A. Although the Company intends to administer the Plan to prevent taxation under Section
409A, the Company does not represent or warrant that the Plan or any Award complies with any provision of federal, state, local or other
tax law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">24.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Unfunded Obligation</U>. Grantees shall have the status of general unsecured creditors of the Company. Any amounts payable to
Grantees pursuant to the Plan shall be unfunded and unsecured obligations for all purposes, including, without limitation, Title I of
the Employee Retirement Income Security Act of 1974, as amended. Neither the Company nor any Related Entity shall be required to segregate
any monies from its general funds, or to create any trusts, or establish any special accounts with respect to such obligations. The Company
shall retain at all times beneficial ownership of any investments, including trust investments, which the Company may make to fulfill
its payment obligations hereunder. Any investments or the creation or maintenance of any trust or any Grantee account shall not create
or constitute a trust or fiduciary relationship between the Administrator, the Company or any Related Entity and a Grantee, or otherwise
create any vested or beneficial interest in any Grantee or the Grantee&rsquo;s creditors in any assets of the Company or a Related Entity.
The Grantees shall have no claim against the Company or any Related Entity for any changes in the value of any assets that may be invested
or reinvested by the Company with respect to the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">25.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Construction</U>.
Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of
the Plan. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular.
Use of the term &ldquo;or&rdquo; is not intended to be exclusive, unless the context clearly requires otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 142.6pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>eyen-20220616.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaOBmbOdzZR+yYkxtmB5bVmq/y4laugCDyMINi8WwTkN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:eyen="http://eyenoviabio.com/20220616" elementFormDefault="qualified" targetNamespace="http://eyenoviabio.com/20220616">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://eyenoviabio.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="eyen-20220616_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="eyen-20220616_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>eyen-20220616_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>eyen-20220616_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://eyenoviabio.com/role/Cover" xlink:href="eyen-20220616.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://eyenoviabio.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139955627857144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 16, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 16,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EYENOVIA,
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001682639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-1178401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">295 Madison Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 2400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">289-1117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EYEN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>tm2218686d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="eyen-20220616.xsd" xlink:type="simple"/>
    <context id="From2022-06-16to2022-06-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682639</identifier>
        </entity>
        <period>
            <startDate>2022-06-16</startDate>
            <endDate>2022-06-16</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-06-16to2022-06-16">0001682639</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-06-16to2022-06-16">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-06-16to2022-06-16">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-06-16to2022-06-16">2022-06-16</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-06-16to2022-06-16">EYENOVIA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-06-16to2022-06-16">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-06-16to2022-06-16">001-38365</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-06-16to2022-06-16">47-1178401</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-06-16to2022-06-16">295 Madison Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-06-16to2022-06-16">Suite 2400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-06-16to2022-06-16">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-06-16to2022-06-16">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-06-16to2022-06-16">10017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-06-16to2022-06-16">917</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-06-16to2022-06-16">289-1117</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-06-16to2022-06-16">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-06-16to2022-06-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-06-16to2022-06-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-06-16to2022-06-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-06-16to2022-06-16">Common     stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-06-16to2022-06-16">EYEN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-06-16to2022-06-16">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-06-16to2022-06-16">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2022-06-16to2022-06-16">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;
M 4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " #+,]%4EXJ[',     3 @
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MY68R#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\@RX/J!5Z0B?
M:ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'!=09#K+&))@G6
M0VY6= ;N\N@#FW+()FKJIBF>HPYX4P[V1D\E5!B@?%.9J+SV4VPYZ8Y>9WK_
M,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " #+,]%4)!Z;HJT   #X 0
M&@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I
M0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LID
MR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\
M./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6
M?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ RS/15&60>9(9 0
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M<',O87!P+GAM;%!+ 0(4 Q0    ( ,LST50C1M_7[@   "L"   1
M      "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( ,LST529
M7)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N
M>&UL4$L! A0#%     @ RS/15&&,AKQL!   <Q$  !@              ("!
M#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( ,LST52?
MH!OPL0(  .(,   -              "  :\,  !X;"]S='EL97,N>&UL4$L!
M A0#%     @ RS/15)>*NQS     $P(   L              ( !BP\  %]R
M96QS+RYR96QS4$L! A0#%     @ RS/15*K$(A8S 0  (@(   \
M     ( !=!   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,LST50D'INB
MK0   /@!   :              "  =01  !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( ,LST51ED'F2&0$  ,\#   3
M  "  ;D2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(   ,4
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2218686d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eyenoviabio.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2218686d1_8k.htm">tm2218686d1_8k.htm</File>
    <File>eyen-20220616.xsd</File>
    <File>eyen-20220616_lab.xml</File>
    <File>eyen-20220616_pre.xml</File>
    <File>tm2218686d1_ex10-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2218686d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm2218686d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "eyen-20220616_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "eyen-20220616_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "eyen-20220616.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "eyen",
   "nsuri": "http://eyenoviabio.com/20220616",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2218686d1_8k.htm",
      "contextRef": "From2022-06-16to2022-06-16",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://eyenoviabio.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2218686d1_8k.htm",
      "contextRef": "From2022-06-16to2022-06-16",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://eyenoviabio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001104659-22-072110-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-22-072110-xbrl.zip
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M_P0^4!SE?R2V#61Y:32]3-,L_P)02P,$%     @ RS/15&V'L-W_"@  ;(<
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M.K=< #;;8&BB@,BP.P/0J,2H4",A]P;''4\VF.\72=33;9A"MWA 1MM\Z*J
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M:!Z R="'B!1DLA>L,M W7PL2;45_N9\>KY9)GMI./$V)L_X),%?W3EIZ$'P
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M!5A%L5XW5#+^0B8/ ABJ7$'*I8LO@5OTP2WWB*'"'_M4QX\/':Q;Y 6@<B?
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MQ\ZCY,@?CM7.))E1-TTEO!AN;+"@"Y=5%?!;:M\:=G-6IKQN2W#*<73@T2[
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M'Y5PFU0@5V#D0@UE#;,.['9>7AJR=69K05/00(ZBUW_:2'R&A1*DB9^!2$\
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M0]3>@= 9P*"#5P;'MY+R%?5^% "R;Q19L#]O:#167/5-;)^:(_4KC(2$@(9
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M9PEO(D]3$Z8$W6UY=51VL1K\.N4*2^6D8$G364<M%0;2\U95R7V8A"DZG/]
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MM8F')\IYXP/ZD%6Y?:X)VCKYJ'-G7#>/J2_V2;\YG;2 (7*XI&FECZ6#'!-
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M"O8Y>#U8%L2]W[73ZJX]V<4Z1/^PH$3\W$?4:W6R^,J+;BLALZ9P>>+>CM"
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MO+_A'MZP6QS]]<.CQR'VA1[SU?.W+__W&?[C'V<___3L_P=02P$"% ,4
M" #+,]%4M[[S9#P#  #^"P  $0              @ $     97EE;BTR,#(R
M,#8Q-BYX<V102P$"% ,4    " #+,]%4;8>PW?\*  !LAP  %0
M    @ %K P  97EE;BTR,#(R,#8Q-E]L86(N>&UL4$L! A0#%     @ RS/1
M5,^+DSA7!P  QU@  !4              ( !G0X  &5Y96XM,C R,C V,39?
M<')E+GAM;%!+ 0(4 Q0    ( ,LST52&S]6)6Q@  ("R   2
M  "  2<6  !T;3(R,3@V.#9D,5\X:RYH=&U02P$"% ,4    " #+,]%4JI1<
ME(9:  #82 ( %@              @ &R+@  =&TR,C$X-C@V9#%?97@Q,"TQ
:+FAT;5!+!08     !0 % $D!  !LB0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
